用CAR NK细胞向HER2-阳性固体瘤:CD44表达是HER2-特定CAR NK细胞效率的关键调节器
Bence Gergely1, Márk A Vereb1, István Rebenku1
1Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Cancers
|March 13, 2025
概括
化学抗原受体 (CAR) NK细胞对HER2阳性瘤有前途,但在耐药病例中,它们的有效性受到瘤微环境的限制. 需要进一步优化,以克服细胞外矩阵障碍,以提高治疗潜力.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 针对HER2阳性瘤的单克隆抗体疗法面临抗药性.
- 化学抗原受体 (CAR) NK细胞提供了与CAR T细胞相比更少副作用的替代方案.
- 汽车NK细胞适用于现成应用.
研究的目的:
- 研究 HER2 特定的 CAR NK-92 细胞系,用于治疗 HER2 阳性瘤.
- 评估不同CAR代和辅助刺激领域的疗效.
- 为了评估CAR NK细胞的性能与对Trastuzumab敏感和耐药瘤模型进行比较.
主要方法:
- 使用逆转录病毒转导生成 HER2 特定的 CAR NK-92 细胞系.
- 集成的第一,第二和第三代CAR具有CD28和/或41BB共刺激域.
- 用于纯CARNK细胞产品的FACS分类和扩展;在体外,3D球形和体内异种移植模型的功能基准测试.
主要成果:
- 卡尔NK细胞在试验室单层培养物中显示出对trastuzumab敏感和耐药瘤的有效性.
- 在3D球状体和体内异种移植模型中观察到对CD44+逆祖祖马布耐药瘤的有效性降低.
- 瘤微环境,特别是细胞外基质,显著阻碍了CAR NK细胞在耐药瘤中的有效性.
结论:
- 卡尔NK细胞疗法显示出潜力,但由于瘤微环境,在耐药瘤中面临挑战.
- 提高CAR NK细胞透率和克服细胞外矩阵障碍的策略至关重要.
- 优化CAR构造和输送方法对于在瘤学中推进CARNK细胞治疗是必要的.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823


